Trials / Terminated
TerminatedNCT02579122
REVIparin-BRIDging-in a General Practice Setting in GErmany
REVIparin-BRIDging-in a General Practice Setting in GErmany (REVIBRIDGE). Non-interventional Study to Evaluate Reviparin for Prevention of Thrombosis and Thromboembolism in General and Orthopedic Surgery (Here: for Perioperative Bridging of Oral Anticoagulation in Interventional Procedures) in General Practices
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 77 (actual)
- Sponsor
- Mylan Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
In view of the fact that little is known about the pre- and post-interventional coagulation management of phenprocoumon patients with reviparin at general practices in Germany, an observational study is being initiated to evaluate the effectiveness and tolerability of reviparin in the area of outpatient, general practice-based care in the context of bridging therapy. Patients for whom bridging therapy with low-molecular weight heparin (LMWH) was specified and for whom the LMWH reviparin was chosen for this purpose shall be investigated.
Conditions
Timeline
- Start date
- 2015-10-01
- Primary completion
- 2016-07-01
- Completion
- 2016-07-01
- First posted
- 2015-10-19
- Last updated
- 2022-03-31
Locations
11 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT02579122. Inclusion in this directory is not an endorsement.